Domov › Metastatski rak › Texas › Dallas
Klinične študije za Metastatski rak v Dallas, TX
42 študij za Metastatski rak išče udeležence na lokacijah v Dallas in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Vključevanje udeležencevFaza 2
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Vključevanje udeležencevFaza 1/2
- UT Southwest Simmons Cancer Center, Dallas
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Vključevanje udeležencevFaza 1
- Texas Oncology, Dallas
- University of Texas Southwestern Medical Center, Dallas
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- UT Southwestern, Dallas
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- SCRI at Mary Crowley, Dallas
- University of Texas Southwestern Medical Center, Dallas
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Vključevanje udeležencevFaza 2/3
- Texas Oncology- Baylor Charles A. Sammons Cancer Center, Dallas
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Vključevanje udeležencevFaza 3
- Research Site, Dallas
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Vključevanje udeležencevFaza 2
- University of Texas Southwestern Medical Center, Dallas
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Vključevanje udeležencevFaza 1/2
- The University of Texas Southwestern Medical Center - Harold C Simmons Comprehensive Cancer Center, Dallas
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Vključevanje udeležencevFaza 2/3
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
- University of Texas Southwestern Medical Center-Zale Lipshy University Hospital, Dallas
- in še 1
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Oncology, Dallas
- SCRI at Mary Crowley, Dallas
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Texas Oncology - DFW, Dallas
- Texas Oncology - DFW, Dallas
- Texas Oncology - DFW, Dallas
- in še 2
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Vključevanje udeležencevFaza 1
- Texas Oncology - DFW (Sammons CC), Dallas
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Vključevanje udeležencevFaza 3
- UT Southwestern Medical Center, Dallas
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Vključevanje udeležencevFaza 3
- Parkland Health and Hospital System, Dallas
- UT Southwestern Medical Center, Dallas
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Vključevanje udeležencevFaza 3
- Parkland Health and Hospital System, Dallas
- USO - Texas Oncology, Dallas
- UT Southwestern Medical Center, Dallas
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Vključevanje udeležencevFaza 1/2
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
- University of Texas Southwestern Simmons Cancer Center - Redbird, Dallas
- in še 2
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- Clinical Study Site, Dallas
A Study of KK2269 in Adult Participants With Solid Tumors
Vključevanje udeležencevFaza 1
- The University of Texas Southwestern Medical Center, Dallas
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Vključevanje udeležencevFaza 1/2
- Avenzo Therapeutics Recruiting Site, Dallas
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Vključevanje udeležencevFaza 3
- Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
- Mary Crowley Cancer Research, Dallas
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- University of Texas Southwestern Medical Center, Dallas
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Vključevanje udeležencevFaza 1
- University of Texas Southwestern, Dallas
- Texas Oncology, P.A, Dallas
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- Mary Crowley Cancer Research, Dallas
- Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Vključevanje udeležencevFaza 1
- Mary Crowley Cancer Research Center, Dallas
A Study of PYX-201 in Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Dallas, Dallas
Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central Lung
Vključevanje udeležencevZgodnja faza 1
- University of Texas Southwestern Medical Center, Dallas
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Vključevanje udeležencevFaza 3
- Old Parkland Hospital Hematology Oncology Clinic, Dallas
- UT Southwestern Medical Center, Dallas
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Vključevanje udeležencevFaza 1
- Sarah Cannon Research Institute at Mary Crowley, Dallas
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Vključevanje udeležencevFaza 1
- Sarah Cannon Research Institute at Mary Crowley, Dallas
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Vključevanje udeležencevFaza 1/2
- Mary Crowley Cancer Research, Dallas
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Vključevanje udeležencevFaza 2/3
- UT Southwestern Medical Center, Dallas
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Vključevanje udeležencevFaza 1/2
- Next Oncology, Dallas
- UTSW Medical Center, Dallas
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Dallas, Dallas
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- NEXT Oncology - Dallas, Dallas
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Vključevanje udeležencevFaza 1
- Mary Crowley Cancer Research, Dallas
- Baylor University Medical Center, Dallas
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Vključevanje udeležencevFaza 1
- Urology Clinics of North Texas, Dallas
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- Texas Oncology - Baylor Charles A Sammons Cancer Center, Dallas
Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer
Vključevanje udeležencevFaza 2
- University of Texas Southwestern Medical Center, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Dallas
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Mary Crowley Cancer Research, Dallas
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
Vključevanje udeležencevFaza 1
- Texas Oncology, Dallas
Študije za Metastatski rak v drugih mestih
- Houston, TX104 študij
- New York City, NY93 študij
- Nashville, TN70 študij
- Boston, MA63 študij
- Los Angeles, CA57 študij
- St. Louis, MO54 študij
- Arlington, VA53 študij
- Philadelphia, PA46 študij
- Chicago, IL45 študij
- San Antonio, TX44 študij
- Washington, DC43 študij
- Seattle, WA39 študij
Druge študije v Dallas
- Rak dojke55 študij
- Nemalicelični pljučni rak52 študij
- Srčno popuščanje42 študij
- Rak (vse vrste)37 študij
- Rak prostate36 študij
- Kolorektalni rak33 študij
- Debelost30 študij
- Rak jajčnikov28 študij
- Rak pljuč27 študij
- Rak mehurja27 študij
- Rak endometrija24 študij
- Rak ledvic (renocelularni karcinom)23 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.